Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$70.23 - $86.01 $18,470 - $22,620
263 Added 6.98%
4,032 $291,000
Q4 2022

Feb 14, 2023

BUY
$67.18 - $84.11 $48,974 - $61,316
729 Added 23.98%
3,769 $302,000
Q3 2022

Nov 14, 2022

BUY
$66.18 - $82.86 $201,187 - $251,894
3,040 New
3,040 $203,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16.3B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Advisor Partners Ii, LLC Portfolio

Follow Advisor Partners Ii, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Partners Ii, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisor Partners Ii, LLC with notifications on news.